Leonteq Securities AG’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21M Sell
150,000
-100
-0.1% -$2.66K 0.16% 108
2025
Q4
$3.74M Buy
150,100
+50,100
+50% +$1.26M 0.11% 140
2025
Q3
$2.55M Sell
100,000
-500,000
-83% -$12.3M 0.08% 178
2025
Q2
$14.5M Buy
600,000
+450,000
+300% +$10.5M 0.56% 34
2025
Q1
$3.81M Sell
150,000
-4,000
-3% -$105K 0.21% 89
2024
Q4
$4.09M Hold
154,000
0.28% 88
2024
Q3
$4.46M Buy
154,000
+54,000
+54% +$1.58M 0.34% 67
2024
Q2
$2.8M Sell
100,000
-150,000
-60% -$4.13M 0.2% 93
2024
Q1
$6.94M Sell
250,000
-100,000
-29% -$2.77M 0.52% 41
2023
Q4
$10.1M Hold
350,000
0.57% 38
2023
Q3
$11.6M Hold
350,000
0.64% 35
2023
Q2
$12.8M Buy
350,000
+150,000
+75% +$5.84M 0.66% 37
2023
Q1
$8.16M Buy
+200,000
New +$8.64M 0.37% 53

Other funds holding PFE

Leonteq Securities AG's PFE Position: Q1 2026 in Review

Leonteq Securities AG reduced its Pfizer (PFE) stake by 84% in Q1 2026, selling an estimated $16.9M and leaving 122,401 shares worth $3.44M. The position accounts for 0.13% of the portfolio, ranked #131.

Leonteq Securities AG first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $26.2M in Q2 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Leonteq Securities AG held 122,401 shares of Pfizer worth $3.44M as of Q1 2026.
  • Leonteq Securities AG sold 633,016 Pfizer shares in Q1 2026, an estimated $16.9M.
  • Pfizer made up 0.13% of Leonteq Securities AG's portfolio in Q1 2026, its #131 holding.
  • Leonteq Securities AG first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Pfizer position peaked at $26.2M in Q2 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.